Non-Small Cell Lung Cancer

What is Non-Small Cell Lung Cancer ?

Non-small cell lung cancer, or NSCLC, occurs most frequently. It makes up about 80 to 85 percent of all lung cancer cases. Lung cancer begins when abnormal cells develop in the lungs and grow uncontrollably. These cancerous cells form tumors. Tumors can spread to nearby tissues and to distant parts of the body through the blood and lymphatic systems.

Lungs are an important part of the body. It is because they help in breathing. Oxygen is supplied to our bloodstream from the lungs. Carbon dioxide is also expelled by the lungs. In the case of lung cancer, the lungs are severely affected.

Multiple key differences exist between non-small cell lung cancer and small cell lung cancer. The non-small cell lung cancer (NSCLC) disease progresses at a slower pace than most small cell lung cancer (SCLC) cases, and it allows for treatment through multiple medical methods, which include surgical operations, radiation treatments, chemotherapy, targeted therapies, and immunotherapy.

The treatment success rate is much higher when the condition is diagnosed early, since most patients are diagnosed at advanced stages because of minimal symptoms at disease onset. The development of advanced imaging technology, along with the availability of numerous treatment methods, has transformed the approach towards the condition.

What are the primary types of non-small cell lung cancer?

The classification of non-small cell lung cancer identifies various types of the condition, which depend on the cell types from which the cancerous cells develop.

Other Rare Subtypes

The less frequent forms of non-small cell lung cancer (NSCLC) include the following types:

The rare variants exhibit unique characteristics that require specialized treatment methods.

  1. Adenocarcinoma

    The most common subtype of NSCLC, or non-small cell lung cancer, is adenocarcinoma. The disease arises from cells that create mucus and other respiratory fluids found in lung tissue. This lung cancer type appears mainly in the outer lung areas, which affect both smokers and non-smokers.

    The growth rate of adenocarcinoma proceeds at a slower pace when compared to most lung cancer types, but this disease still possesses the ability to spread to lymph nodes and distant body parts.

  2. Squamous Cell Carcinoma

    The flat cells that line the lung airways serve as the starting point for squamous cell carcinoma. The tumor typically develops in the central lung area, adjacent to the primary bronchi.

    The development of this lung cancer type occurs mainly among people who smoke tobacco products continuously throughout their lives.

  3. Large Cell Carcinoma

    The rare form of NSCLC, large cell carcinoma, can develop in any lung region. The disease spreads throughout the body at a faster rate compared to other types of non-small cell lung cancer.

    • Adenosquamous carcinoma
    • Sarcomatoid carcinoma
    • Pleomorphic carcinoma

What are the Symptoms & Causes of Non-Small Cell Lung Cancer ?

Symptoms of Non-Small Cell Lung Cancer

The symptoms of NSCLC (non-small cell lung cancer) depend on the tumor dimension and position, together with any cancer dissemination to other body areas.

The main symptoms comprise:

  • A persistent cough that shows no signs of improvement
  • Chest pain that intensifies during deep breathing and coughing sessions
  • Shortness of breath
  • Hoarseness
  • Wheezing
  • Unexplained weight loss
  • Loss of appetite
  • Fatigue or weakness

Patients develop recurrent lung infections, including pneumonia and bronchitis.

A person coughs up blood (hemoptysis)

The body develops new symptoms as lung cancer spreads to other regions. The following are examples of cases:

  • The patient experiences bone pain when the cancer reaches the bones.
  • The patient develops headaches with neurological symptoms when the cancer spreads to the brain.
  • The liver damage results in skin and eye yellowing

Some patients may not experience noticeable symptoms in the early stages of the disease.

Causes of Non-Small Cell Lung Cancer

Non-small cell lung cancer develops when genetic changes occur in lung cells, allowing them to grow and divide without control.

The abnormal cells keep multiplying until they grow tumors, enter nearby tissues, and spread to other parts of the body.

The environmental and lifestyle factors that affect lung cancer risk also contribute to genetic mutations, although their exact mechanisms remain unknown.

What are the Risk Factors for Non-Small Cell Lung Cancer ?

The development of non-small cell lung cancer risk receives a heightening influence from multiple risk factors.

Tobacco Smoking

Lung cancer develops primarily due to tobacco smoking.

Smoking risk increases with both the number of cigarettes smoked and the duration of smoking.

The risk of developing health problems increases through exposure to secondhand smoke.

Exposure to Radon Gas

Radon gas is identified as a radioactive gas produced by natural processes that can accumulate indoors. Excessive exposure to high radon levels enhances the risk of lung cancer.

Some workers face occupational hazards that raise lung cancer risk. This includes exposure to asbestos and to certain work-related substances:

  • Asbestos
  • Arsenic
  • Nickel
  • Chromium
  • Diesel exhaust

Occupational Hazards

Workplace exposure to certain substances can heighten lung cancer risk through contact with asbestos, arsenic, nickel, chromium, and diesel exhaust.

Air Pollution

Urban air pollution increases lung cancer risk among people exposed to it over long periods.

Family History

People who have a family history of lung cancer face a greater risk of developing this illness.

Previous Radiation Therapy

Radiation therapy to the chest area increases lung cancer risk for patients who received this treatment for other types of cancer.

How is Non-Small Cell Lung Cancer Diagnosed & Tested ?

Non-small cell lung cancer diagnosis requires doctors to use imaging studies and laboratory tests together with tissue examination methods.

Medical History & Physical Examination

Doctors begin their evaluation by reviewing the patient's medical records and current health problems. The physical examination process can identify breathing abnormalities and lymph node swelling.

Imaging Tests

Doctors use imaging tests to determine whether there are any lung problems that require further investigation.

Some commonly used imaging tests are:

Chest X-ray

Such a test order is for lung imaging.

CT Scan

A CT scan provides images of the lungs, giving detailed pictures of any cancerous growth in the lungs, which would be impossible to detect using an X-ray.

MRI Scan

Doctors use magnetic resonance imaging (MRI) to investigate whether cancer has extended to the brain or spinal cord.

Sputum Cytology

A sample of mucus that a person coughs up from the lungs is sometimes analyzed under a microscope to find cancer cells.

Biopsy

Non-small cell lung cancer diagnosis requires biopsy confirmation. The doctor obtains a small tissue sample, which a pathologist will study to establish the diagnosis.

Several biopsy techniques may be used:

  • Bronchoscopy
  • Needle biopsy
  • Endobronchial ultrasound-guided biopsy
  • Surgical biopsy

The biopsy helps identify the type and molecular characteristics of the lung cancer.

Molecular & Genetic Testing

Molecular tests are becoming essential for diagnosing non-small cell lung cancer. The doctor examines the tumor sample to detect genetic changes.

Examples of targetable mutations include:

  • Mutations in the EGFR genes
  • Arrangement of ALK genes
  • Changes in ROS1 genes
  • Mutations in the BRAF genes

Medical practitioners use mutation identification to recommend targeted treatment options that achieve higher success rates in certain individuals. The success rate is evaluated based on the advancement stage of cancer.

How is non-small cell lung cancer staged from Stage 0 to Stage IV?

TNM staging for non-small cell lung cancer is done using three parameters:

  • The tumor's size and extent (T)
  • Involvement of lymph nodes (N)
  • Metastasis (M)

Stages 0 through 4 are the stages.

Stage 0 (Carcinoma in Situ)

The cancer remains confined to the airway linings, without invading deeper tissues, without spreading to any lymph nodes.

Stage II

The tumor may involve nearby lymph nodes or nearby lung structures.

Stage III

Cancer spreads d to the lymph nodes in the chest or to surrounding tissues.

The current stage has three levels, which include IIIA, IIIB, and IIIC, based on how far the cancer has spread.

Stage IV

The disease has advanced to remote areas of the body, including the brain, liver, bones, and adrenal glands. All lung cancers require assessment of multiple factors, including disease stage, NSCLC type, patient health status, and tumor molecular traits.

What treatment options exist for NSCLC ?

Surgery

Doctors recommend surgery for patients with early-stage NSCLC who have their cancer limited to lung tissue.

The common surgical procedures include:

  • Lobectomy - It is a procedure to remove an entire lobe of the lung
  • Segmentectomy - This term applies to the removal of part of a lung lobe
  • Pneumonectomy - removal of an entire lung

During surgery, doctors will remove nearby lymph nodes to assess whether cancer has spread from the primary tumor site.

Radiation Therapy

Radiation therapy uses high-energy beams to exterminate or destroy cancer cells.

The treatment can be applied in these situations:

  • It gets used after surgical procedures to remove all remaining cancer cells.
  • The treatment becomes the primary option when surgical procedures cannot be performed.

Doctors use advanced radiation techniques to directly attack tumors while protecting healthy tissues from radiation exposure.

Chemotherapy

Chemotherapy uses drugs that destroy rapidly dividing cancer cells.

The treatment may be given through three different time points, which include:

  • Neoadjuvant therapy helps to decrease tumor size before surgical procedures.
  • Adjuvant therapy helps to decrease the possibility of cancer returning after surgery.
  • The treatment serves as the main approach to managing patients with advanced cancer.

Doctors frequently combine chemotherapy with other medical treatments.

Targeted Therapy

Targeted therapy drugs attack specific genetic abnormalities present in cancer cells.

The treatments prevent cancer cells from receiving the signals they need to grow and divide.

Patients with specific tumor mutations will benefit significantly from targeted therapy.

Immunotherapy

Immunotherapy helps in strengthening the immune system so it can identify and eliminate cancer cells.

Patients with NSCLC may be treated with immune checkpoint inhibitors, which can prolong survival by alleviating symptoms.

The supportive treatments help to treat:

  • Pain
  • Breathing difficulties
  • Fatigue
  • Emotional stress

What is the prognosis for non-small cell lung cancer patients?

The prognosis for non-small cell lung cancer patients depends on various determining factors.

Prognosis depends on two important factors, which include:

  • Stage at diagnosis
  • Tumor characteristics
  • Overall health of the patient
  • Response to treatment

Patients diagnosed in early stages have significantly better outcomes than those diagnosed at advanced stages.

Improved molecular tests, coupled with the design of immunotherapies, have led to better patient outcomes in NSCLC. These include all cases, though some measures can help prevent lung cancer.

People need to follow these guidelines for risk prevention:

  • Tobacco smoking should be completely avoided.
  • The public needs to decrease its exposure to secondhand smoke.
  • People should test their homes for radon.
  • Workers must avoid contact with hazardous workplace substances.
  • People need to adopt wholesome lifestyle patterns to safeguard their health.

High-risk individuals will benefit from early cancer detection through low-dose CT scans, which provide better results.

Why choose Tender Palm Super Speciality Hospital for Non-Small Cell Lung Cancer Treatment in Lucknow, India?

Tender Palm Super-Speciality Hospital offers advanced Non-Small Cell Lung Cancer treatment in Lucknow, India, at an affordable cost. We have a team of experienced thoracic surgeons and oncology specialists who provide accurate diagnosis and both non-surgical and surgical treatment options including surgical resection, targeted therapy, and immunotherapy. Our Thoracic Surgery and Oncology team has decades of experience in successfully treating Non-Small Cell Lung Cancer in Lucknow, India.

To seek an Expert consultation for Non-Small Cell Lung Cancer Treatment in Lucknow, India:

Call us at +91-9076972161
Email at care@tenderpalm.com

Call +91 9076972161
Request an Appointment
Mon - Sat 9:00 AM to 6:00 PM IST

Our Experts

Awards & Accreditations